Béres Gyógyszergyár to invest HUF 3.2 bln in plant
Hungarian pharmaceutical company Béres Gyógyszergyár will invest HUF 3.2 bln at its unit in Szolnok, central Hungary, with HUF 1.6 bln being derived from government funding, Hungaryʼs foreign minister Péter Szijjártó said yesterday, according to Hungarian news agency MTI.
Béres will increase production capacity, add 1,600 sqm to its production area and 400 sqm to its logistics warehouse, install new technology, develop the infrastructure and create 60 new jobs, Szijjártó said.
Chairman József Béres, whose father invented the companyʼs flagship product, said Béres Gyógyszergyár has so far invested HUF 3.3 bln at its Szolnok unit, acquired in 1995. The company employs 340 including the 215 at the Szolnok plant.
The company has funded its developments primarily from internal sources, supplemented with HUF 296 mln in government funding obtained through tenders. Béres Gyógyszergyár, founded as a family business 25 years ago, is known in Hungary for manufacturing immune boosters. It controls 35% of that market, Béres said.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.